Zantac / Ranitidine (NDMA Cancer) Statistics in Indianapolis
~2.2 million
Indianapolis Metro Population
~180
Est. Annual Bladder Cancer Diagnoses (Marion County)
2 years from discovery (Daubert)
IN SOL
Eli Lilly HQ — major pharmaceutical industry community
Pharma Sector
Courts in Indianapolis, Indiana
Marion County Superior Court — Civil Division
200 E Washington St, Indianapolis, IN 46204
U.S. District Court, Southern District of Indiana — Indianapolis Division
46 E Ohio St, Indianapolis, IN 46204
Hospitals & Trauma Centers in Indianapolis
IU Simon Comprehensive Cancer Center
535 Barnhill Dr, Indianapolis, IN 46202
Community Health Network Cancer Care
7950 Castleway Dr, Indianapolis, IN 46250
Liability Considerations in Indianapolis
Zantac Litigation in Indianapolis
Indianapolis is the pharmaceutical capital of the Midwest — home to Eli Lilly and a sophisticated pharmaceutical litigation community. Indiana applies Daubert under I.R.E. 702. Indianapolis-area Zantac claimants should consult national plaintiffs' counsel about Delaware Superior Court filing options, where Judge Medinilla's docket provides the most favorable Zantac litigation posture. The federal Zantac MDL (No. 2924, S.D. Florida) was largely dismissed in 2022 after Judge Robin Rosenberg excluded plaintiffs' causation experts under Daubert. However, the Delaware Superior Court under Judge Vivian Medinilla continues to actively hear Zantac cases and has allowed causation experts to proceed. Defendants Sanofi, Boehringer Ingelheim, GSK, and Pfizer are all actively litigating in Delaware. For most claimants, filing in Delaware Superior Court through national plaintiffs' counsel is now the primary path forward.
Resources for Indianapolis Zantac Claimants
Indianapolis-area Zantac claimants should gather pharmacy records from Walgreens, CVS, Kroger, and Meijer pharmacies. IU Simon Cancer Center records documenting bladder, esophageal, stomach, or colorectal cancer diagnosis, staging, and treatment are critical evidence. Indiana's 2-year SOL requires prompt consultation with qualified Zantac plaintiffs' counsel.